2013
DOI: 10.1093/ajh/hpt018
|View full text |Cite
|
Sign up to set email alerts
|

Sildenafil Increases Sympathetically Mediated Vascular Tone in Humans

Abstract: Sildenafil increased sympathetically mediated vascular tone in middle-aged healthy men. Alpha-adrenergic-mediated vasoconstriction may offset vasodilation during PDE-5 inhibition and may explain the significant hypotension observed in patients taking alpha-blockers with sildenafil.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
17
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(17 citation statements)
references
References 39 publications
0
17
0
Order By: Relevance
“…While sildenafil citrate is not associated with clinically significant changes in systemic hemodynamic parameters (Jackson et al 1999), it may cause increases in muscle sympathetic nerve activity (MSNA) and plasma norepinephrine (Dopp et al 2013; Phillips et al 2000). Enhanced vasoconstriction due to an increase in MSNA could partially mask any increase in exercise hyperemia as a result of sildenafil citrate.…”
Section: Discussionmentioning
confidence: 99%
“…While sildenafil citrate is not associated with clinically significant changes in systemic hemodynamic parameters (Jackson et al 1999), it may cause increases in muscle sympathetic nerve activity (MSNA) and plasma norepinephrine (Dopp et al 2013; Phillips et al 2000). Enhanced vasoconstriction due to an increase in MSNA could partially mask any increase in exercise hyperemia as a result of sildenafil citrate.…”
Section: Discussionmentioning
confidence: 99%
“…Although at first sight this is surprising, it is notable that PDE5 inhibition by sildenafil does not reverse hypertension induced by chronic inhibition of NOS in the rat 28 and second, in humans, it is associated with increased sympathetic outflow 29 and increased sympathetically mediated vascular tone. 30 Central actions of sildenafil increasing sympathetic outflow may offset local peripheral vasodilation and explain why local intra-arterial administration of sildenafil induces forearm vasodilation 31,32 but systemic administration does not. 30,33 It is possible that increased α-adrenergic activity inhibits nNOS-mediated vasodilation, as has been shown for eNOS responses, 34 and that this outweighs any effects on cGMP.…”
Section: Discussionmentioning
confidence: 99%
“…30 Central actions of sildenafil increasing sympathetic outflow may offset local peripheral vasodilation and explain why local intra-arterial administration of sildenafil induces forearm vasodilation 31,32 but systemic administration does not. 30,33 It is possible that increased α-adrenergic activity inhibits nNOS-mediated vasodilation, as has been shown for eNOS responses, 34 and that this outweighs any effects on cGMP. Increased sympathetic outflow in hypertensive subjects could explain both the blunted nNOS response to mental stress and the lack of effect of sildenafil to further enhance high sympathetic outflow, and hence lack of effect to influence nNOS responses in these subjects.…”
Section: Discussionmentioning
confidence: 99%
“…The PDE5 inhibitor sildenafil citrate reduces vagal activation and increases sympathetic modulation in men with chronic heart failure (Piccirillo et al 2002), although this probably occurs through its reflex vasodilatory action. Moreover, sildenafil significantly increases plasma noradrenaline concentration in healthy middle-aged men (Dopp et al 2013) and alleviates functional muscle ischaemia in boys with Duchenne muscular dystrophy in a dose-dependent manner (Nelson et al 2014). Lee et al (2015) recently found that PDE9A protein expression is upregulated during hypertrophy and cardiac failure.…”
Section: Pdes As Therapeutic Targets In Cardiac Dysautonomiamentioning
confidence: 99%
“…Moreover, sildenafil significantly increases plasma noradrenaline concentration in healthy middle‐aged men (Dopp et al . ) and alleviates functional muscle ischaemia in boys with Duchenne muscular dystrophy in a dose‐dependent manner (Nelson et al . ).…”
Section: Introductionmentioning
confidence: 99%